[	O
Activation	O
of	O
sterol	O
regulatory	O
element	O
binding	O
protein	O
and	O
its	O
involvement	O
in	O
endothelial	B-Cell
cell	I-Cell
migration	O
]	O

OBJECTIVE	O
:	O
To	O
study	O
the	O
activation	O
of	O
sterol	O
regulatory	O
element	O
binding	O
protein	O
(	O
SREBP	O
)	O
and	O
its	O
critical	O
role	O
in	O
endothelial	B-Cell
cell	I-Cell
migration	O
.	O

METHODS	O
:	O
Bovine	O
aortic	B-Cell
endothelial	I-Cell
cells	I-Cell
(	O
ECs	B-Cell
)	O
were	O
cultured	O
.	O

The	O
expression	O
of	O
SREBP	O
and	O
Cdc42	O
were	O
determined	O
by	O
Western	O
blot	O
and	O
quantitative	O
real	O
-	O
time	O
PCR	O
.	O

Moreover	O
,	O
outward	O
growth	O
migration	O
model	O
and	O
transwell	O
chamber	O
assay	O
were	O
used	O
to	O
detect	O
ECs	B-Cell
migration	O
.	O

RESULTS	O
:	O
(	O
1	O
)	O
SREBP	O
was	O
activated	O
during	O
ECs	B-Cell
migration	O
.	O

Western	O
blot	O
analysis	O
demonstrated	O
increased	O
active	O
form	O
SREBP	O
in	O
migrating	O
as	O
compared	O
to	O
non	O
-	O
migrating	O
ECs	B-Cell
population	O
.	O

SREBP	O
activation	O
decreased	O
as	O
ECs	B-Cell
migration	O
slowed	O
;	O
(	O
2	O
)	O
Coincidental	O
with	O
SREBP	O
activation	O
,	O
mRNA	O
expression	O
of	O
its	O
target	O
genes	O
such	O
as	O
low	O
density	O
lipoprotein	O
receptor	O
,	O
HMG	O
-	O
CoA	O
reductase	O
,	O
and	O
fatty	O
acid	O
synthase	O
also	O
increased	O
in	O
migrating	O
ECs	B-Cell
population	O
as	O
detected	O
by	O
real	O
-	O
time	O
PCR	O
;	O
(	O
3	O
)	O
Migration	O
induced	O
SREBP	O
activation	O
in	O
ECs	B-Cell
was	O
inhibited	O
by	O
SREBP	O
-	O
acting	O
protein	O
RNAi	O
and	O
pharmacologically	O
by	O
25	O
-	O
hydroxycholesterol	O
;	O
(	O
4	O
)	O
Inhibition	O
of	O
SREBP	O
led	O
to	O
decreased	O
ECs	B-Cell
migration	O
in	O
various	O
models	O
;	O
(	O
5	O
)	O
Cells	B-Cell
genetically	O
deficient	O
in	O
SREBP	O
-	O
acting	O
protein	O
,	O
S1P	O
,	O
or	O
S2P	O
,	O
phenotypically	O
exhibited	O
impaired	O
migration	O
;	O
(	O
6	O
)	O
SREBP	O
inhibition	O
in	O
ECs	B-Cell
suppressed	O
the	O
activity	O
of	O
small	O
GTPase	O
Cdc42	O
,	O
a	O
key	O
molecule	O
for	O
ECs	B-Cell
motility	O
.	O

CONCLUSIONS	O
:	O
SREBP	O
is	O
activated	O
during	O
and	O
plays	O
a	O
critical	O
role	O
in	O
ECs	B-Cell
migration	O
.	O

Targeting	O
SREBP	O
could	O
become	O
a	O
novel	O
approach	O
in	O
fighting	O
diseases	O
involving	O
abnormal	O
ECs	B-Cell
migration	O
.	O

